2026 is becoming a defining year for pharmacy benefits. In just one week, PBM reform laws were passed, the FTC reached a landmark settlement with Express Scripts, and TrumpRx launched into the market. Together, these developments are poised to reshape the pharmacy landscape, and it’s important for benefit leaders to understand the potential impacts ahead.
Thank you to everyone who joined us for this webinar, where Truveris experts broke down what these developments mean for plan sponsors, advisors, and members, highlighting how new reporting standards, formulary rules, and DTC channels are influencing transparency, benefit design, cost management, and member experience.
You can access the recording of this session above.
Learning Objectives
- Understand the Impact of 2026 PBM Reform Laws: Gain clarity on new federal requirements, including full rebate pass‑through, expanded transparency mandates, and structured reporting for both Commercial and Medicare markets, and what these changes mean for PBM accountability and plan oversight.
- Evaluate the Effects of the FTC–Express Scripts Settlement: Explore how mandated changes to ESI formulary practices, pricing methodologies, GPO reshoring, and data disclosures will influence costs, member out‑of‑pocket calculations, and competitive dynamics across PBMs.
- Assess the Role of TrumpRx and the Rise of DTC Drug Purchasing: Understand how the launch of the TrumpRx platform is shaping consumer expectations around price comparison, access to cash‑pay drug options, and potential implications for future price negotiations and benefit design alignment.
About the Speakers:
Sarah Berry, PharmD, Clinical Director
Sarah Berry, Clinical Director at Truveris, brings more than twelve years of experience in pharmacy benefit management, procurement strategy, and plan optimization. Sarah holds a Doctor of Pharmacy degree from the University of South Carolina–Columbia.
Aya Desouki, PharmD, Clinical Director
Aya Desouki, Clinical Director at Truveris, brings seven years of experience in pharmacy benefit and clinical consulting from BCBS (Florida Blue), Cigna, and Denver Health Medical Plan. She specializes in formulary strategy, drug cost management, and clinical program design. Aya holds a Doctor of Pharmacy from Lipscomb University.
Truveris is a pharmacy cost containment company dedicated to reducing pharmacy costs and driving transparency for employers and benefit consultants. Our proprietary, data-driven technology and deep industry expertise empower smarter pharmacy benefit decisions through contract optimization and PBM oversight. Independent and unbiased, Truveris delivers measurable savings and accountability across every pharmacy program.
